Legacy Financial Advisors, Inc. Exact Sciences Corp Transaction History
Legacy Financial Advisors, Inc.
- $527 Million
- Q2 2025
A detailed history of Legacy Financial Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 14,245 shares of EXAS stock, worth $991,309. This represents 0.14% of its overall portfolio holdings.
Number of Shares
14,245
Previous 14,245
-0.0%
Holding current value
$991,309
Previous $616,000
22.73%
% of portfolio
0.14%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
659Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.27 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$840 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$835 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$374 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...